Ameloblastoma is a benign odontogenic tumor generally present in the jaw bone. The purpose of this study was to evaluate the clinicopathological profile, treatment and its outcome in a consecutive case series of 8 cases involving mandible and also other tumor like conditions of mandible mimicking ameloblastoma. A total of 10 patients were treated over period of 4 years, which were retrospectively reviewed in our institution. Imaging (CT scan) was done in all the cases and Biopsy was done in 9 cases. Of the 10 patients, 6 males and 4 females were identified. The average age was 25.1 years (range 7-46 years). Swelling in the region of mandible was the only complaint in all the patients. Segmental mandibulectomy was done with free fibular graft was done in 8 cases, Hemimandibulectomy without reconstruction was done in one case and reconstruction with titanium plate was done in another case. All patients underwent grossly complete surgical removal of the lesions, and no recurrence occurred during the follow-up period. The clinical profile and outcome may provide some insights into the differential diagnosis and clinical management. The best treatment option available is surgical excision with either autologous graft or prosthetic implant which can result in a good prognosis and cosmesis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.